Can Fite Biopharma Stock Price on October 9, 2024

CANF Stock  USD 1.74  0.02  1.14%   
If you're considering investing in Can Stock, it is important to understand the factors that can impact its price. As of today, the current price of Can Fite stands at 1.74, as last reported on the 26th of February, with the highest price reaching 1.81 and the lowest price hitting 1.68 during the day. Can Fite Biopharma secures Sharpe Ratio (or Efficiency) of -0.0509, which signifies that the company had a -0.0509 % return per unit of risk over the last 3 months. Can Fite Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Can Fite's Risk Adjusted Performance of (0.02), mean deviation of 3.61, and Standard Deviation of 5.24 to double-check the risk estimate we provide.
  
Can Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0509

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCANF

Estimated Market Risk

 5.24
  actual daily
46
54% of assets are more volatile

Expected Return

 -0.27
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Can Fite is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Can Fite by adding Can Fite to a well-diversified portfolio.

Related Headline

Avenue Therapeutics Headline on 9th of October 2024

MIAMI, Oct. 09, 2024 -- Avenue Therapeutics, Inc. , a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Alexandra MacLean, M.D., Chief Executive Officer of Avenue Therapeutics, will participate in a fireside chat at Maxim Groups 2024 Healthcare Virtual Summit on Tuesday, October 15, 2024 at 130 PM ET. The fireside chat will be av

Can Fite Valuation on October 9, 2024

It is possible to determine the worth of Can Fite on a given historical date. On October 9, 2024 Can was worth 2.15 at the beginning of the trading date compared to the closed value of 2.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Can Fite stock. Still, in general, we apply an absolute valuation method to find Can Fite's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Can Fite where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Can Fite's related companies.
 Open High Low Close Volume
  2.01    2.26    2.00    2.04    230,631  
10/09/2024
  2.15    2.55    2.10    2.35    435,383  
  2.31    2.36    2.19    2.25    101,773  
Backtest Can Fite  |  Can Fite History  |  Can Fite Valuation   PreviousNext  
Open Value
2.15
2.35
Closing Value
17.88
Upside

Can Fite Trading Date Momentum on October 9, 2024

On October 10 2024 Can Fite Biopharma was traded for  2.25  at the closing time. The top price for the day was 2.36  and the lowest listed price was  2.19 . The trading volume for the day was 101.8 K. The trading history from October 10, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.26% . The overall trading delta against the current closing price is 22.98% .

Can Fite Biopharma Fundamentals Correlations and Trends

By evaluating Can Fite's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Can Fite's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Can financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Can Fite Stock history

Can Fite investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Can is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Can Fite Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Can Fite stock prices may prove useful in developing a viable investing in Can Fite
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. Can-Fite BioPharma Ltd. was incorporated in 1994 and is headquartered in Petah Tikva, Israel. Can-Fite Biopharma operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 8 people.

Can Fite Stock Technical Analysis

Can Fite technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Can Fite technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Can Fite trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Can Fite Period Price Range

Low
February 26, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Can Fite Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Can Fite February 26, 2025 Market Strength

Market strength indicators help investors to evaluate how Can Fite stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Can Fite shares will generate the highest return on investment. By undertsting and applying Can Fite stock market strength indicators, traders can identify Can Fite Biopharma entry and exit signals to maximize returns

Can Fite Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Can Fite's price direction in advance. Along with the technical and fundamental analysis of Can Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Can to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Can Stock analysis

When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites